The Australia healthcare staffing market was valued at USD 242.58 million in 2024 and is projected to grow from USD 262.48 million in 2025 to reach USD 493.02 million by 2033, growing at a CAGR of 8.20% during the forecast period (2025–2033).
Report Scope:

Report Metric	Details
Market Size in 2024	USD 242.58 Million
Market Size in 2025	USD 262.48 Million
Market Size in 2033	USD 493.02 Million
CAGR	8.2% (2025-2033)
Base Year for Estimation	2024
Historical Data	2021-2023
Forecast Period	2025-2033
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Segments Covered	By Service,By End User,By Region.

Australia Health Insurance: Number of Insured Persons: Hospital Treatment: by Type: Hospital Treatment Only data was reported at 12,751.000 Person in Dec 2024. This records an increase from the previous number of 12,552.000 Person for Sep 2024. Australia Health Insurance: Number of Insured Persons: Hospital Treatment: by Type: Hospital Treatment Only data is updated quarterly, averaging 14,953.500 Person from Sep 1997 (Median) to Dec 2024, with 110 observations. The data reached an all-time high of 2,132,122.000 Person in Sep 2000 and a record low of 2,875.000 Person in Dec 2015. Australia Health Insurance: Number of Insured Persons: Hospital Treatment: by Type: Hospital Treatment Only data remains active status in CEIC and is reported by Australian Prudential Regulation Authority. The data is categorized under Global Database’s Australia – Table AU.RG005: Health Insurance: Number of Insured Persons.

IntroductionDespite available safe hormonal and non-hormonal interventions, most women with troublesome menopausal symptoms do not receive effective, evidence-based therapy, with notable international disparities in provision. This study aimed to investigate self-reported menopausal care experiences in a self-selecting sample from five English-speaking countries: Australia, Canada, New Zealand, the United Kingdom, and the United States, through an anonymous online survey.MethodsThe 15–20 min survey, delivered via Qualtrics XM®, included questions on sociodemographic characteristics and treatment experiences, such as the number of healthcare professionals (HCP) seen before getting a prescription, ease of obtaining treatment, involvement in treatment discussions, appropriateness of treatment review and optimization, side effect tolerability, and overall satisfaction.ResultsData from 3,062 respondents were analyzed: Australia (16.59%, n = 508), Canada (17.54%, n = 537), New Zealand (16.59%, n = 508), UK (24.00%, n = 735), and US (25.28%, n = 774). Significant international differences were observed in both healthcare access and prescribing patterns. More women in the UK and US consulted an HCP compared with Australia, Canada, and New Zealand [χ²(4, N = 3062) = 101.02, p 

Snapshot img

Hospital Furniture Market Size 2024-2028

The hospital furniture market size is valued to increase by USD 8 billion, at a CAGR of 8.06% from 2023 to 2028. Rise in international accreditation by hospitals will drive the hospital furniture market.

Market Insights

APAC dominated the market and accounted for a 28% growth during the 2024-2028.
By Application - Physician furniture segment was valued at USD 6.00 billion in 2022
By Product - Hospital beds segment accounted for the largest market revenue share in 2022

Market Size & Forecast

Market Opportunities: USD 100.81 billion 
Market Future Opportunities 2023: USD 8.00 billion
CAGR from 2023 to 2028 : 8.06%

Market Summary

The market is experiencing significant growth due to the increasing international accreditation of healthcare facilities. This trend is driven by the need for modern, functional, and compliant furniture solutions that enhance patient care and operational efficiency. The aging population is another major factor fueling market expansion, as hospitals must accommodate the unique needs of an increasingly geriatric patient base. However, the market is not without challenges. The limited sustainability of smaller companies in the global arena poses a significant threat, as larger players with greater resources and economies of scale continue to dominate. In a real-world business scenario, a hospital may seek to optimize its supply chain by partnering with a single furniture company capable of providing a comprehensive range of products and services, ensuring both cost savings and regulatory compliance. This strategic approach allows the hospital to focus on its core mission: delivering high-quality care to its patients.

What will be the size of the Hospital Furniture Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free SampleThe market continues to evolve, with a focus on enhancing patient comfort and adhering to regulatory compliance. One significant trend is the integration of medical-grade plastics and latex-free materials in furniture production. These materials ensure easy cleanability, durability, and resistance to disinfection techniques, crucial for maintaining a hygienic hospital environment. Furniture regulatory compliance is another essential consideration in the procurement process. Ergonomic assessment tools and staff workspace ergonomics are essential for ensuring staff efficiency and reducing workplace injuries. Space optimization strategies, such as modular furniture systems, are increasingly popular due to their adaptability and cost-effectiveness. Moreover, patient-centric designs are gaining traction, with an emphasis on accessibility features like wheelchair ramps and posture support systems. Pediatric and geriatric furniture cater to specific patient populations, addressing their unique needs. Hospital bed sensors and antimicrobial coatings contribute to improved patient care and safety. Furniture durability testing and UV sterilization are essential aspects of the furniture life cycle, ensuring the longevity and effectiveness of hospital furniture investments. As hospitals prioritize sustainability, eco-friendly and recyclable materials are becoming increasingly important in the furniture industry. In conclusion, the market is undergoing continuous transformation, with a focus on patient comfort, regulatory compliance, and sustainability. These trends directly impact key decision areas such as budgeting, product strategy, and operational efficiency.

Unpacking the Hospital Furniture Market Landscape

Hospital furniture plays a pivotal role in optimizing operational efficiency and enhancing patient care within healthcare facilities. Compared to traditional designs, adjustable height desks in hospital settings have shown a 25% increase in ergonomic chair features, leading to reduced musculoskeletal disorders among staff. Furthermore, medical cart design incorporating pressure ulcer prevention materials has demonstrated a 30% reduction in pressure ulcer incidents. Hospital bed automation and fall prevention furniture have improved patient safety by 40%, reducing the risk of falls and associated injuries. Hospital furniture maintenance, including sterilization methods and disinfection efficacy, ensures infection control protocols are met, contributing to improved patient outcomes. Durability is a key consideration, with healthcare furniture boasting a 50% longer lifespan compared to standard office furniture. Additionally, wheelchair maneuverability in patient rooms has been enhanced through thoughtful layout design, improving accessibility and patient flow.

Key Market Drivers Fueling Growth

The increase in international accreditation for hospitals serves as the primary catalyst for market growth. The market is experiencing significant evolution, driven by the internat

Australia Employment: Part Time: Females: Health Care & Social Assistance: Medical & Other Health Care Services data was reported at 239.548 Person th in Feb 2025. This records a decrease from the previous number of 247.954 Person th for Nov 2024. Australia Employment: Part Time: Females: Health Care & Social Assistance: Medical & Other Health Care Services data is updated quarterly, averaging 100.373 Person th from Nov 1984 (Median) to Feb 2025, with 162 observations. The data reached an all-time high of 273.281 Person th in Aug 2023 and a record low of 36.300 Person th in Nov 1984. Australia Employment: Part Time: Females: Health Care & Social Assistance: Medical & Other Health Care Services data remains active status in CEIC and is reported by Australian Bureau of Statistics. The data is categorized under Global Database’s Australia – Table AU.G025: Employment: by Sex and by Industry: Part Time.

Australia Health Insurance: Number of Insured Persons data was reported at 15,329,755.000 Person in Sep 2025. This records an increase from the previous number of 15,222,442.000 Person for Jun 2025. Australia Health Insurance: Number of Insured Persons data is updated quarterly, averaging 11,666,700.000 Person from Sep 1995 (Median) to Sep 2025, with 121 observations. The data reached an all-time high of 15,329,755.000 Person in Sep 2025 and a record low of 5,915,922.000 Person in Jun 1997. Australia Health Insurance: Number of Insured Persons data remains active status in CEIC and is reported by Australian Prudential Regulation Authority. The data is categorized under Global Database’s Australia – Table AU.RG: Health Insurance: Number of Insured Persons.

The market is expected to reach USD 16.0 million by 2025 and is likely to grow at an estimated 4.6% CAGR from 2025 to 2035.

Attributes	Details
Estimated Value (2035)	USD 16.0 million
Value-based CAGR (2025 to 2035)	4.6%

Market Concentration

Vendor Tier	Tier 1
Key Vendors	Indivior, Alkermes, Camurus
Market Share (%)	60%
Description	Global leaders offering MAT solutions, including long-acting buprenorphine and extended-release naltrexone.

Vendor Tier	Tier 2
Key Vendors	Teva Pharmaceuticals, Aspen Pharma
Market Share (%)	25%
Description	Regional manufacturers providing affordable MAT options and generic formulations.

Vendor Tier	Tier 3
Key Vendors	Harm Reduction Australia, Telehealth NZ
Market Share (%)	15%
Description	Non-profits and digital health platforms delivering accessible and innovative care solutions.

The global sales of home healthcare software is estimated to be worth USD 4,330.8 million in 2025 and anticipated to reach a value of USD 9,702.0 million by 2035. Sales are projected to rise at a CAGR of 8.4% over the forecast period between 2025 and 2035. The revenue generated by home healthcare software in 2024 was USD 3,995.2 million. The industry is anticipated to exhibit a Y-o-Y growth of 8.2% in 2025.

Attributes	Key Insights
Historical Size, 2024	USD 3,995.2 million
Estimated Size, 2025	USD 4,330.8 million
Projected Size, 2035	USD 9,702.0 million
Value-based CAGR (2025 to 2035)	8.4%

Semi Annual Market Update

Particular	Value CAGR
H1	9.1% (2024 to 2034)
H2	8.8% (2024 to 2034)
H1	8.4% (2025 to 2035)
H2	7.9% (2025 to 2035)

Country-wise Insights

Countries	Value CAGR (2025 to 2035)
United States	7.9%
Germany	7.1%
Japan	6.3%
UK	5.4%
China	8.1%
India	8.7%
Australia	7.4%

Category-wise Insights

Product	Clinical Management Systems (CMS)
Value Share (2025)	34.4%

By Usage	Clinical Homecare Systems
Value Share (2035)	52.0%

Australia Office Furniture Market size was valued at USD 2.4 Billion in 2024 and is projected to reach USD 3.8 Billion by 2032, growing at a CAGR of 5.92% from 2025 to 2032.

Australia Office Furniture Market: Definition/Overview

Office furniture refers to the essential furnishings used in workspaces to support various tasks and activities. It includes items such as desks, chairs, filing cabinets, shelves, and conference tables, all designed to improve productivity, organization, and comfort within an office environment. These pieces are typically made from materials like wood, metal, or plastic and come in a wide range of styles, sizes, and configurations to meet the needs of different industries and work setups.

Supplementary tables for the manuscript titled Randomised controlled trial evaluating the use of Zoledronic acid in Duchenne Muscular Dystrophy by Zacharin M, Lim A, Gryllakis J, Siafarikis A, Jefferies C, Briody J, Heather N, Pitkin J, Emmanuel J, Lee K, Wang XF, Simm PJ, Munns CF

Health care costs and health outcomes for base case by sex over the life course of the Brisbane adult population (95% uncertainty interval).

Australia Respiratory Care Devices Market is anticipated to reach an exponential growth in the upcoming five years. Australia Respiratory Care Devices Market - Industry Size, Share, Trends, Competition, Opportunity and Forecast 2027 By Product Type, By Indication, By End User, By Region, Competition Forecast & Opportunities, 2027

Pages	70
Market Size
Forecast Market Size
CAGR
Fastest Growing Segment
Largest Market
Key Players

Health Insurance: No of Policies: Hospital Treatment: by Type: Hospital Treatment Only data was reported at 6,742.000 Unit in Sep 2025. This records a decrease from the previous number of 6,775.000 Unit for Jun 2025. Health Insurance: No of Policies: Hospital Treatment: by Type: Hospital Treatment Only data is updated quarterly, averaging 7,753.000 Unit from Sep 1995 (Median) to Sep 2025, with 121 observations. The data reached an all-time high of 1,082,202.000 Unit in Sep 2000 and a record low of 2,372.000 Unit in Dec 2015. Health Insurance: No of Policies: Hospital Treatment: by Type: Hospital Treatment Only data remains active status in CEIC and is reported by Australian Prudential Regulation Authority. The data is categorized under Global Database’s Australia – Table AU.RG: Health Insurance: Number of Policies.

Ramsay Health Care - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Nov 2025.Data for Ramsay Health Care including historical, tables and charts were last updated by Trading Economics this last November in 2025.

This dataset presents the footprint of the number and rate of emergency department presentations in public hospitals by patient location. Mental health-related emergency department (ED) presentations are defined as presentations to public hospital EDs that have a principal diagnosis of mental and behavioural disorders. However, the definition does not fully capture all potential mental health-related presentations to EDs such as intentional self-harm, as intent can be difficult to identify in an ED environment and can also be difficult to code. The data spans the financial years of 2014-2018 and is aggregated to Statistical Area Level 3 (SA3) geographic areas from the 2016 Australian Statistical Geography Standard (ASGS).

State and territory health authorities collect a core set of nationally comparable information on most public hospital ED presentations in their jurisdiction, which is compiled annually into the National Non-Admitted Patient Emergency Department Care Database (NNAPEDCD). The data reported for 2014–15 to 2017–18 is sourced from the NNAPEDCD. Information about mental health-related services provided in EDs prior to 2014–15 was supplied directly to the Australian Institute of Health and Welfare (AIHW) by states and territories.

Mental health services in Australia (MHSA) provides a picture of the national response of the health and welfare service system to the mental health care needs of Australians. MHSA is updated progressively throughout each year as data becomes available. The data accompanies the Mental Health Services - In Brief 2018 Web Report.

For further information about this dataset, visit the data source:Australian Institute of Health and Welfare - Mental health services in Australia Data Tables.

Please note:

• AURIN has spatially enabled the original data.

• Caution is required when conducting time-series analyses. The data source changed in 2014–15 from data provided by state and territory health authorities (2004–05 to 2013–14) to the NNAPEDCD. Additionally, due to the methodology applied for mapping the data over time, years prior to 2017–18 may be an undercount or data may not be displayed where SA3s have changed over time.

• Mental health-related emergency department presentations included in this report are those that had a principal diagnosis that fell within the Mental and behavioural disorders chapter (Chapter 5) of ICD-10-AM (codes F00–F99) or the equivalent ICD-9-CM or SNOMED codes. It does not include codes for self-harm or poisoning.

• From 2014–15 onwards, diagnosis information was not reported using a uniform classification. The mapping of SNOMED codes (used by NSW) to ICD-10AM may lead to an under-estimation of mental health-related presentations.

• Changes in the volume of patients over time for NSW may be attributed, in part, to the increased number of hospitals included in the data for this jurisdiction.

Australia Regenerative Medicine Market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027, on the account of advancing medicines and growing expenses over advancement of the pharmaceutical products. Regenerative Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2027 By Type, By Application, By End User, By Region, Competition Forecast & Opportunities, 2027

Pages	70
Market Size
Forecast Market Size
CAGR
Fastest Growing Segment
Largest Market
Key Players

Change in prevalent cases and mortality over the life course of the Brisbane adult population (95% uncertainty interval).

The Australia Sleep Apnea Devices market was valued at USD 161.58 Million in 2024 and is expected to reach USD 260.58 Million by 2030 with a CAGR of 8.25%.

Pages	85
Market Size	2024: USD 161.58 Million
Forecast Market Size	2030: USD 260.58 Million
CAGR	2025-2030: 8.25%
Fastest Growing Segment	Therapeutic Devices
Largest Market	Capitol Territory & New South Wales
Key Players	1. Fisher & Paykel Healthcare Corporation Limited 2. SomnoMed Limited 3. Compumedics Limited 4. ResMed Inc (Australia) 5. Philips Australia 6. Oventus Medical Australia 7. WellOZ Australia 8. Bespoke Medical Innovations Pty Ltd 9. DeVilbiss Healthcare Pty Ltd. 10. Invacare Australia Pty Ltd.

This dataset presents the footprint of the percentage of adults who saw a GP for urgent medical care in the preceding 12 months. The data spans the years of 2013-2017 and is aggregated to 2015 Department of Health Primary Health Network (PHN) areas, based on the 2011 Australian Statistical Geography Standard (ASGS).

The data is sourced from the Australian Bureau of Statistics (ABS) 2016-17 Patient Experience Survey, collected between 1 July 2016 and 30 June 2017. It also includes data from previous Patient Experience Surveys conducted in 2013-14, 2014-15 and 2015-16. The Patient Experience Survey is conducted annually by the ABS and collects information from a representative sample of the Australian population. The Patient Experience Survey is one of several components of the Multipurpose Household Survey, as a supplement to the monthly Labour Force Survey. The Patient Experience Survey collects data on persons aged 15 years and over, who are referred to as adults for this data collection.

For further information about this dataset, visit the data source:Australian Institute of Health and Welfare - Patient experiences in Australia Data Tables.

Please note:

• AURIN has spatially enabled the original data using the Department of Health - PHN Areas.

• Percentages are calculated based on counts that have been randomly adjusted by the ABS to avoid the release of confidential data.

• As an indication of the accuracy of estimates, 95% confidence intervals were produced. These were calculated by the ABS using standard error estimates of the proportion.

• Some of the patient experience measures for 2016-17 have age-standardised rates presented. Age-standardised rates are hypothetical rates that would have been observed if the populations studied had the same age distribution as the standard population.

• Crude rates are provided for all years. They should be used for understanding the patterns of actual service use or level of experience in a particular PHN.

• The Patient Experience Survey excludes persons aged less than 15 years, persons living in non-private dwellings and the Indigenous Community Strata (encompassing discrete Aboriginal and Torres Strait Islander communities).

• Data for Northern Territory should be interpreted with caution as the Patient Experience Survey excluded the Indigenous Community Strata, which comprises around 25% of the estimated resident population of the Northern Territory living in private dwellings.

• Rows that contain a "#" in "Interpret with Caution" indicates that the estimate has a relative standard error of 25% to 50%, which indicates a high level of sampling error relative to its value and must be taken into account when comparing this estimate with other values.

• NP - Not available for publication. The estimate is considered to be unreliable. Values assigned to NP in the original data have been set to null.

This dataset presents the footprint of the percentage of adults who reported excellent, very good or good health. The data spans the years of 2013-2017 and is aggregated to 2015 Department of Health Primary Health Network (PHN) areas, based on the 2011 Australian Statistical Geography Standard (ASGS).

The data is sourced from the Australian Bureau of Statistics (ABS) 2016-17 Patient Experience Survey, collected between 1 July 2016 and 30 June 2017. It also includes data from previous Patient Experience Surveys conducted in 2013-14, 2014-15 and 2015-16. The Patient Experience Survey is conducted annually by the ABS and collects information from a representative sample of the Australian population. The Patient Experience Survey is one of several components of the Multipurpose Household Survey, as a supplement to the monthly Labour Force Survey. The Patient Experience Survey collects data on persons aged 15 years and over, who are referred to as adults for this data collection.

For further information about this dataset, visit the data source:Australian Institute of Health and Welfare - Patient experiences in Australia Data Tables.

Please note:

• AURIN has spatially enabled the original data using the Department of Health - PHN Areas.

• Percentages are calculated based on counts that have been randomly adjusted by the ABS to avoid the release of confidential data.

• As an indication of the accuracy of estimates, 95% confidence intervals were produced. These were calculated by the ABS using standard error estimates of the proportion.

• Some of the patient experience measures for 2016-17 have age-standardised rates presented. Age-standardised rates are hypothetical rates that would have been observed if the populations studied had the same age distribution as the standard population.

• Crude rates are provided for all years. They should be used for understanding the patterns of actual service use or level of experience in a particular PHN.

• The Patient Experience Survey excludes persons aged less than 15 years, persons living in non-private dwellings and the Indigenous Community Strata (encompassing discrete Aboriginal and Torres Strait Islander communities).

• Data for Northern Territory should be interpreted with caution as the Patient Experience Survey excluded the Indigenous Community Strata, which comprises around 25% of the estimated resident population of the Northern Territory living in private dwellings.

• Rows that contain a "#" in "Interpret with Caution" indicates that the estimate has a relative standard error of 25% to 50%, which indicates a high level of sampling error relative to its value and must be taken into account when comparing this estimate with other values.

• NP - Not available for publication. The estimate is considered to be unreliable. Values assigned to NP in the original data have been set to null.